Americans are dealing with the ongoing pollen season, providing Flonase an opportunity to promote its solutions to allergy sufferers in a quirky way. At the heart of the company’s recent Allergic to ...
In a head-to-head prescription versus over-the-counter drug battle, prescription wins. At least when it comes to advertising. TV ad spending for the top 10 prescription drugs tallied $876.3 million, ...
A battle for kids' pollen proclivities is shaping up this allergy season. Both Sanofi's ($SNY) Nasacort and GlaxoSmithKline's ($GSK) Flonase have introduced children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback